1. Home
  2. PLBC vs SCLX Comparison

PLBC vs SCLX Comparison

Compare PLBC & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLBC
  • SCLX
  • Stock Information
  • Founded
  • PLBC 1980
  • SCLX 2011
  • Country
  • PLBC United States
  • SCLX United States
  • Employees
  • PLBC N/A
  • SCLX N/A
  • Industry
  • PLBC Finance Companies
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLBC Finance
  • SCLX Health Care
  • Exchange
  • PLBC Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • PLBC 236.7M
  • SCLX 34.3M
  • IPO Year
  • PLBC 2005
  • SCLX N/A
  • Fundamental
  • Price
  • PLBC $45.09
  • SCLX $6.65
  • Analyst Decision
  • PLBC Buy
  • SCLX Strong Buy
  • Analyst Count
  • PLBC 4
  • SCLX 3
  • Target Price
  • PLBC $55.75
  • SCLX $367.50
  • AVG Volume (30 Days)
  • PLBC 14.8K
  • SCLX 85.9K
  • Earning Date
  • PLBC 07-25-2025
  • SCLX 08-12-2025
  • Dividend Yield
  • PLBC 2.67%
  • SCLX N/A
  • EPS Growth
  • PLBC 3.33
  • SCLX N/A
  • EPS
  • PLBC 4.95
  • SCLX N/A
  • Revenue
  • PLBC $84,001,000.00
  • SCLX $50,710,000.00
  • Revenue This Year
  • PLBC $19.95
  • SCLX $107.00
  • Revenue Next Year
  • PLBC $22.19
  • SCLX $82.52
  • P/E Ratio
  • PLBC $9.07
  • SCLX N/A
  • Revenue Growth
  • PLBC 9.14
  • SCLX 7.79
  • 52 Week Low
  • PLBC $35.76
  • SCLX $3.60
  • 52 Week High
  • PLBC $51.33
  • SCLX $73.50
  • Technical
  • Relative Strength Index (RSI)
  • PLBC 59.76
  • SCLX 56.81
  • Support Level
  • PLBC $45.37
  • SCLX $6.20
  • Resistance Level
  • PLBC $46.34
  • SCLX $6.64
  • Average True Range (ATR)
  • PLBC 1.17
  • SCLX 0.41
  • MACD
  • PLBC 0.13
  • SCLX 0.05
  • Stochastic Oscillator
  • PLBC 64.16
  • SCLX 67.19

About PLBC Plumas Bancorp

Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: